Telix Pharmaceuticals (ASX:TLX) Other Stockholders Equity : A$0.0 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Telix Pharmaceuticals Other Stockholders Equity?

Telix Pharmaceuticals's Other Stockholders Equity for the quarter that ended in Dec. 2024 was A$0.0 Mil.

Telix Pharmaceuticals's quarterly Other Stockholders Equity declined from Dec. 2023 (A$0.0 Mil) to Jun. 2024 (A$0.0 Mil) but then stayed the same from Jun. 2024 (A$0.0 Mil) to Dec. 2024 (A$0.0 Mil).

Telix Pharmaceuticals's annual Other Stockholders Equity increased from Dec. 2022 (A$0.0 Mil) to Dec. 2023 (A$0.0 Mil) but then declined from Dec. 2023 (A$0.0 Mil) to Dec. 2024 (A$0.0 Mil).

Telix Pharmaceuticals Other Stockholders Equity Historical Data

The historical data trend for Telix Pharmaceuticals's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telix Pharmaceuticals Other Stockholders Equity Chart

Telix Pharmaceuticals Annual Data

Trend

Sep99

Sep00

Jun17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Stockholders Equity

Get a 7-Day Free Trial

Telix Pharmaceuticals Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Stockholders Equity	Get a 7-Day Free Trial										-	-	-	-	-

Telix Pharmaceuticals Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Telix Pharmaceuticals Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Telix Pharmaceuticals's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Telix Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telix Pharmaceuticals Ltd (ASX:TLX) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

TLX:USA TLPPF:USA T3X:Germany

Address

55 Flemington Road, Suite 401, North Melbourne, Melbourne, VIC, AUS, 3051

Website

https://www.telixpharma.com

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.